Literature DB >> 28815550

Fertility preservation in women with borderline ovarian tumors - how does it impact disease outcome? A cohort study.

Limor Helpman1,2, Assaf Yaniv2, Mario E Beiner1,2, Sarit Aviel-Ronen1,2, Tamar Perri1,2, Gilad Ben-Baruch1,2, Liat Hogen Ben-David1, Ariella Jakobson-Setton1, Jacob Korach1,2.   

Abstract

INTRODUCTION: Borderline ovarian tumors are typically indolent neoplasms. Since many are diagnosed in younger women, fertility conservation is an important consideration and has been advocated based on retrospective data. The objective of this study was to identify features impacting on recurrence and survival in a series of borderline ovarian tumors, and to assess the safety of a fertility-sparing approach.
MATERIAL AND METHODS: A historical cohort study of consecutive borderline ovarian tumors cases treated at a single institution over 30 years (1981-2011). Data on surgical approach (fertility-sparing or otherwise), disease stage, CA125 levels, histological features, adjuvant treatment and follow-up data were collected. Recurrence and survival were assessed using the Kaplan-Meier method and associations with the variables of interest were evaluated using a multivariate Cox proportional hazards model.
RESULTS: 213 patients were included. Of 132 women age 40 years and below at diagnosis, 112 (85%) had a fertility-sparing procedure and 60 (46%) had conservation of an involved ovary. Fifty patients (24%) developed recurrences; fertility preservation (hazard ratio = 2.57; 95% confidence interval 1.1-6; p = 0.029) and advanced stage (hazard ratio = 4.15; 95% confidence interval 2.3-7.6; p < 0.001) were independently associated with recurrence on multivariate analysis. Eleven (5%) patients died of their disease. Fertility preservation was not associated with compromised survival.
CONCLUSIONS: Borderline ovarian tumors carry a good prognosis overall. Fertility preservation is associated with a higher risk of disease relapse; however, as most relapses are localized and may be salvaged with surgical treatment, overall survival is not compromised.
© 2017 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Borderline ovarian tumors; cystectomy; fertility preservation; ovarian cancer; ovarian conservation; ovarian tumors of low malignant potential

Mesh:

Substances:

Year:  2017        PMID: 28815550     DOI: 10.1111/aogs.13203

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  7 in total

1.  Unilateral cystectomy and serous histology are associated with relapse in borderline ovarian tumor patients with fertility-sparing surgery: a systematic review and meta-analysis.

Authors:  Na Li; Xiu Ming; Zhengyu Li
Journal:  Arch Gynecol Obstet       Date:  2020-08-03       Impact factor: 2.344

2.  Age-dependent difference in impact of fertility preserving surgery on disease-specific survival in women with stage I borderline ovarian tumors.

Authors:  Haiyan Sun; Xi Chen; Tao Zhu; Nanfang Liu; Aijun Yu; Shihua Wang
Journal:  J Ovarian Res       Date:  2018-06-29       Impact factor: 4.234

3.  Outcomes of fertility-sparing surgery for stage II and III serous borderline ovarian tumors.

Authors:  Ziyang Lu; Bin Li; Chao Gu
Journal:  J Int Med Res       Date:  2019-08-21       Impact factor: 1.671

4.  Identification of clinical and molecular features of recurrent serous borderline ovarian tumour.

Authors:  Ziyang Lu; Fanghe Lin; Tao Li; Jinhui Wang; Cenxi Liu; Guangxing Lu; Bin Li; MingPei Pan; Shaohua Fan; Junqiu Yue; He Huang; Jia Song; Chao Gu; Jin Li
Journal:  EClinicalMedicine       Date:  2022-04-08

5.  Risk Factors for Recurrence of Borderline Ovarian Tumours after Conservative Surgery and Impact on Fertility: A Multicentre Study by the Francogyn Group.

Authors:  Adele Ozenne; Marion De Berti; Gilles Body; Xavier Carcopino; Olivier Graesslin; Yohan Kerbage; Cherif Akladios; Cyrille Huchon; Alexandre Bricou; Camille Mimoun; Emilie Raimond; Lobna Ouldamer
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

6.  Management of borderline ovarian tumors: A tertiary referral center experience in Egypt.

Authors:  Khaled Gaballa; Mohamed Abdelkhalek; Adel Fathi; Basel Refky; Khaled Belal; Moustafa Elaraby; Mohammad Zuhdy
Journal:  Front Surg       Date:  2022-09-02

7.  Status of Surgical Management of Borderline Ovarian Tumors in France: are Recommendations Being Followed? Multicentric French Study by the FRANCOGYN Group.

Authors:  Lise Lecointre; Virginie Bund; Eva Sangnier; Lobna Ouldamer; Sofiane Bendifallah; Martin Koskas; Pierre-Adrien Bolze; Pierre Collinet; Geoffroy Canlorbe; Cyril Touboul; Cyrille Huchon; Charles Coutant; Emilie Faller; Thomas Boisramé; Justine Gantzer; Martin Demarchi; Vincent Lavoué; Chérif Akladios
Journal:  Ann Surg Oncol       Date:  2021-04-26       Impact factor: 5.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.